Hard to know. SYC closed lips. Went to presentation last week. Nothing at all beyond slide show and that they are fully funded for PTX 100 registration trial and ongoing running costs with $20 million capital raise. Been slow recruiting extra trial participants. End of this year no matter what will be a full PTX 100 update. No discussion about Cellpryme possible sales after trialling. No excited body language or inferences that something big is coming, which he has been like in past. BUT he is not allowed to say anything. The fact that TF and Rebecca are presenting together is big. Beyond that I think we just have to wait and see.
PTX Price at posting:
7.7¢ Sentiment: Buy Disclosure: Held
